EMPG

Empro Group Inc. Ordinary shares
NASDAQHEALTHCAREMEDICAL DISTRIBUTION

Key Statistics

Market Cap
$143.05M
P/E Ratio
192.89
EPS
$0.09
Beta
52W High
$18.14
52W Low
$2.74
50-Day MA
$17.36
200-Day MA
$17.26
Dividend Yield
Profit Margin
13.70%
Forward P/E
PEG Ratio

About Empro Group Inc. Ordinary shares

Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company is headquartered in Shah Alam, Malaysia.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$5.48M
Gross Profit (TTM)$3.39M
EBITDA$1.27M
Operating Margin36.10%
Return on Equity66.30%
Return on Assets16.40%
Revenue/Share (TTM)$3.66
Book Value$1.02
Price-to-Book90.09
Price-to-Sales (TTM)26.08
EV/Revenue25.33
EV/EBITDA91.72
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)141.60%
Shares Outstanding$8.24M
Float527,720
% Insiders64.82%
% Institutions0.88%

Historical Volatility

HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank

Volatility is currently contracting

Latest News

Empro Group Inc. Announces Receipt of Delinquency Notification from Nasdaq

Selangor, Malaysia, May 22, 2026 (GLOBE NEWSWIRE) -- Empro Group Inc. (Nasdaq: EMPG) (“Empro Group” or the “Company”), a rising beauty and personal care brand headquartered in Malaysia, today announced that on May 19, 2026 it received a notice from The Nasdaq Stock Market stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because the Company has not yet filed its annual report on Form 20-F for the fiscal year ended December 31, 2025.

GlobeNewsWire5/22/2026Neutral
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Empro Group Inc. (NASDAQ: EMPG)

NEW YORK, May 22, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces an investigation of potential securities claims on behalf of shareholders of Empro Group Inc. (NASDAQ: EMPG) (the "Company" or "Empro"). The investigation concerns whether Empro and certain officers and/or directors have engaged in securities fraud or other unlawful business practices.

PRNewsWire5/22/2026Neutral
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Empro Group Inc. (NASDAQ: EMPG)

NEW YORK, May 18, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces an investigation of potential securities claims on behalf of shareholders of Empro Group Inc. (NASDAQ: EMPG)  (the "Company" or "Empro"). The investigation concerns whether Empro and certain officers and/or directors have engaged in securities fraud or other unlawful business practices.

PRNewsWire5/18/2026Neutral
Rosen Law Firm Encourages Empro Group Inc. Investors to Inquire About Securities Class Action Investigation – EMPG

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Empro Group Inc. (NASDAQ: EMPG) resulting from allegations that Empro may have issued materially misleading business information to the investing public. So what: If you purchased Empro securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Ro.

Business Wire4/16/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026